Phase II evaluation of 4ʼ-(9-acridinylamino)-methanesulfon-m-anisidine (AMSA) in patients with advanced head and neck cancers

1982 ◽  
Vol 5 (1) ◽  
pp. 29-32 ◽  
Author(s):  
Vorachai Ratanatharathorn ◽  
Anibal Drelichman ◽  
Maria Sexon-Porte ◽  
Muhyi Al-Sarraf
Keyword(s):  
Head And Neck ◽  
Phase Ii ◽  
Head And Neck Cancers ◽  
Advanced Head

Phase II evaluation of 4ʼ-(9-acridinylamino)-methanesulfon-m-anisidine (AMSA) in patients with advanced head and neck cancers

1982 ◽  
Vol 5 (1) ◽  
pp. 29-32 ◽  
Author(s):  
Vorachai Ratanatharathorn ◽  
Anibal Drelichman ◽  
Maria Sexon-Porte ◽  
Muhyi Al-Sarraf
Keyword(s):  
Head And Neck ◽  
Phase Ii ◽  
Head And Neck Cancers ◽  
Advanced Head

scholarly journals Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study

Cancer ◽  
1994 ◽  
Vol 74 (7) ◽  
pp. 1927-1932 ◽  
Author(s):  
Prakash B Chougule ◽  
Steve Suk ◽  
Quyen D. Chu ◽  
Louis Leone ◽  
Peter T. Nigri ◽  
...  
Keyword(s):  
Head And Neck ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Head And Neck Cancers ◽  
Advanced Head ◽  
Radiation Sensitizer

Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial

2005 ◽  
Vol 75 (2) ◽  
pp. 186-192 ◽  
Author(s):  
Shaleen Kumar ◽  
Manish Pandey ◽  
Punita Lal ◽  
Neeraj Rastogi ◽  
K. Joseph Maria Das ◽  
...  
Keyword(s):  
Head And Neck ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Head And Neck Cancers ◽  
Advanced Head ◽  
Concomitant Boost ◽  
Boost Radiotherapy ◽  
Weekly Cisplatin

A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer

2011 ◽  
Vol 38 (1) ◽  
pp. 108-113 ◽  
Author(s):  
Imjai Chitapanarux ◽  
Vicharn Lorvidhaya ◽  
Ekasit Tharavichitkul ◽  
Somvilai Mayurasakorn ◽  
Pichit Sittitrai ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Advanced Head

scholarly journals Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)

2018 ◽  
Vol 49 (1) ◽  
pp. 37-41 ◽  
Author(s):  
Takashi Matsuzuka ◽  
Naomi Kiyota ◽  
Junki Mizusawa ◽  
Tetsuo Akimoto ◽  
Masato Fujii ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Trial ◽  
Locally Advanced ◽  
Clinical Impact ◽  
Advanced Head

scholarly journals Postoperative Radiotherapy in Head and Neck Cancer

2010 ◽  
Vol 2 (1) ◽  
pp. 43-51
Author(s):  
Vedang Murthy ◽  
Sayan Kundu ◽  
Tanweer Shahid ◽  
Ashwini Budrukkar ◽  
Tejpal Gupta ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Targeted Therapy ◽  
Head And Neck ◽  
Neck Cancer ◽  
Early Stage ◽  
Postoperative Radiotherapy ◽  
Locally Advanced ◽  
Head And Neck Cancers ◽  
Advanced Head ◽  
Locoregional Failure

Abstract Though early stage head and neck cancers can be cured either by surgery or radiation, patients with locally advanced disease continues to pose a therapeutic challenge. Locoregional failure is the major cause of death in head and neck cancers. As the outcome of locally advanced head and neck cancer is less than promising, a combined modality approach is generally undertaken in this group of patients. The combination of surgery, radiation and more recently, chemotherapy and targeted therapy can improve outcomes in locally advanced head and neck cancer patients. This overview discusses the rationale and role of postoperative radiotherapy (PORT) in advanced head and neck cancers, the radiotherapy technique in brief and methods of enhancing the efficacy of postoperative RT by altering the fractionation schedules and adding chemotherapy and targeted therapy.

Sign in / Sign up

Export Citation Format

Share Document